13 research outputs found

    MOESM2 of Aberrant monocyte responses predict and characterize dengue virus infection in individuals with severe disease

    No full text
    Additional file 2: Figure S1. (A) Plasma levels IL-18BPa and free circulating IL-18 in dengue patients at febrile and defeverscence phase. (B) Spearman correlation between IL-18 and IL-18BP among DWS and DWS+/SD. Levels of biomarkers were compared across the three patient groups and post hoc Mann–Whitney U tests were then performed for those biomarkers with a Kruskal–Wallis test P value of <0.05. A Spearman rank test was used to compare the correlation between two continuous variables. ****P < 0.0001, ***P < 0.001, **P < 0.01, and *P < 0.05

    Comparison of Reference Intervals of various populations.

    No full text
    <p>Gaza Strip (N = 50,127)<a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0091968#pone.0091968-Sirdah1" target="_blank">[1]</a>.</p><p>Germany(N = 2967)<a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0091968#pone.0091968-Ittermann1" target="_blank">[6]</a>.</p><p>US (N = 7664) <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0091968#pone.0091968-Beutler1" target="_blank">[4]</a>, (N = not available)<a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0091968#pone.0091968-NHANES1" target="_blank">[5]</a>, (N = not available)<a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0091968#pone.0091968-Hsieh1" target="_blank">[8]</a>.</p><p>UK (N = 700)<a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0091968#pone.0091968-OseiBimpong1" target="_blank">[2]</a>.</p><p>South India(N = 500)<a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0091968#pone.0091968-Subhashree1" target="_blank">[3]</a>.</p><p>Ghana (N = 691)<a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0091968#pone.0091968-Dosoo1" target="_blank">[7]</a>.</p>a<p>19–45 years old.</p>b<p>>45 years old.</p>c<p>20–81 years old.</p>d<p>50–59 years old.</p>e<p>60–69 years old.</p>f<p>19–65 years old.</p>g<p>66 years and above.</p>h<p>16–91 years.</p>i<p>18–70 years.</p>j<p>18–59 years.</p><p>W = White B = Black.</p

    Reference intervals from this study compared with previous study.

    No full text
    <p>M =  male, F =  female.</p><p>* Median, range 2.5-97.5 centiles.</p><p>** Ferritin ng/mL<13 excluded.</p>§<p>Reference interval  =  mean±SD.</p

    Clinical symptoms of the study population.

    No full text
    <p>*indicates the symptoms/manifestations considered as warning signs by the WHO 2009 dengue classification. Detailed clinical symptoms (in percentages) by dengue classification are given in the table.</p

    Clinical profile of study population.

    No full text
    <p>Scatter plot of the study population’s (A) vital signs (temperature, systolic, diastolic and pulse rate); (B) blood profile (hemoglobin, hematocrit, platelet, prothrombin time, activated partial thromboplastin time); (C) white blood cell profile (total white blood cells, lymphocytes, neutrophils and monocytes); (D) liver profile (total protein, total billirubin, albumin, globulin, alkaline phosphatase, alanine transaminase, aspartate aminotransferase) and (E) kidney profile (urea, sodium, potassium, chloride and creatinine) over days of illness. The LOWESS curves follows the general trend of the observed clinical parameter in dengue patients without (blue) and with (red) warning signs. Grey zone shows the reference range values.</p

    Laboratory diagnostics confirmation of study population.

    No full text
    <p>ND: Non dengue; DwoWS: Dengue without warning signs; DwWS: Dengue with warning signs; SD: Severe dengue; IgM: Immunoglobulin M; NS1: Non-structural protein 1; HI: Hemagglutination Inhibiton Assay; +: combination.</p
    corecore